Day 1 :
Time : 09:30-11:00
Minimal access surgery has been recognized as a more friendlier surgery for patients due to its advantages on faster recovery, improved cosmetic results, and reduced postoperative pain. Since its first practice on 1985, by prof Muhe in Germany, laparoscopic cholecystectomy has now been a gold standard. Indonesia started this minimal invasive approach in 1991. Since then, many procedures were done laparoscopically, in line with those of done in developed countries.
The presentation will show current achievements of minimal access surgery. It will also discuss advancements in minimal access surgeries and its future prospects.
Director of Urologic Oncology and Robotic Surgery
Time : 10:45
Rabii Madi is a director of Urologic Oncology and Robotic Surgery He is also the director of Clinical Program & Development at Augusta University Health. His research interest are Nephrology, hypertensions, Dialysis
Introduction: small kidney tumor represents a challenge in management. Options available include active surveillance, partial nephrectomy, radical nephrectomy, radio-frequency ablation (RFA), and cryotherapy. We will discuss the newest literature review of management. Material and Methods: Nephron-sparing procedure are favorable for management of small kidney tumors ( T1a, less than 4 cm in size). The role of tumor biopsy is controversial. Partial nephrectomy (PN) remains the gold standard option that provides a cancer control rate equivalent to radical nephrectomy. Good alternatives to PN include RFA and cryoablation. Radical nephrectomy should be rarely used to treat small kidney tumor. Decisions for management are based on patient’s age, co-morbidities, tumor size, location, and baseline kidney function. Our institutional experience includes 200 cases of robotic partial nephrectomies. Technique and post-operative results will be discussed. Conclusion: management of small kidney tumors includes different options. Robotic partial nephrectomy is the most prescribed surgical option to treat small kidney tumor.